Compounds > 6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline)
Page last updated: 2024-09-03

6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline) and misonidazole

6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline) has been researched along with misonidazole in 1 studies

Compound Research Comparison

Studies
(6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline))		Trials
(6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline))		Recent Studies (post-2010)
(6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline))		Studies
(misonidazole)		Trials
(misonidazole)		Recent Studies (post-2010) (misonidazole)
21001,562139210

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eady, JJ; Haslinger, RK; Peacock, JH; Schlappack, OK; Schmidt, WF1

Other Studies

1 other study(ies) available for 6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline) and misonidazole

ArticleYear
Lack of radiosensitization in Lewis lung carcinoma and a murine plasmacytoma by MTDQ and MTDQ-DA.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1988, Volume: 164, Issue:11

    Topics: Animals; Female; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Misonidazole; Plasmacytoma; Quinolines; Radiation-Sensitizing Agents; Radiotherapy Dosage

1988